Literature DB >> 27780850

Health Status Outcomes in Patients With Acute Myocardial Infarction After Rehospitalization.

Supriya Shore1, Kim G Smolderen2, Kevin F Kennedy2, Philip G Jones2, Suzanne V Arnold2, David J Cohen2, Joshua M Stolker2, Zhenxiang Zhao2, Tracy Y Wang2, P Michael Ho2, John A Spertus2.   

Abstract

BACKGROUND: Rehospitalizations after acute myocardial infarction for unplanned coronary revascularization and unstable angina (UA) are common. However, despite the inclusion of these events in composite end points of many clinical trials, their association with health status has not been studied. METHODS AND
RESULTS: We included 3283 patients with acute myocardial infarction enrolled in a prospective, 24-center US study who had rehospitalizations independently classified by experienced cardiologists. Health status was assessed using Seattle Angina Questionnaire and EuroQol-5D Visual Analog Scale. In the propensity-matched cohorts, 1-year health status was compared between those who did and did not experience rehospitalization for UA or revascularization using a hierarchical linear model. Overall, mean age was 59 years, 33% were women, and 70% were white. Rehospitalization rates for UA and unplanned revascularization at 1 year were 4.3% and 4.7%. One-year Seattle Angina Questionnaire summary scores were worse in patients with rehospitalizations for UA (mean difference, -10.1; 95% confidence interval, -12.4 to -7.9) and unplanned revascularization (mean difference, -5.7; 95% confidence interval, -8.8 to -2.5) when compared with patients without such rehospitalizations. Similarly, EuroQol-5D Visual Analog Scale scores were worse among patients with such readmissions. Individual Seattle Angina Questionnaire domains indicated worse 1-year angina and quality of life outcomes among patients rehospitalized for UA or unplanned revascularization.
CONCLUSIONS: Within the first year after acute myocardial infarction, rehospitalizations for UA and unplanned revascularization are associated with worse health status. These findings highlight the impact of such events from a patient's perspective, beyond their economic impact and support the use of UA and unplanned revascularization as elements of composite end points.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  health status; heart; myocardial infarction; quality of life

Mesh:

Year:  2016        PMID: 27780850      PMCID: PMC5794496          DOI: 10.1161/CIRCOUTCOMES.116.002883

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  22 in total

1.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

Authors:  S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

2.  American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).

Authors:  C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

Review 4.  Validity of composite end points in clinical trials.

Authors:  Victor M Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J Schünemann; Roman Jaeschke; Gordon H Guyatt
Journal:  BMJ       Date:  2005-03-12

5.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

6.  Recurrent myocardial infarction: clinical predictors and prognostic implications.

Authors:  A Marmor; E M Geltman; K Schechtman; B E Sobel; R Roberts
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

7.  Development and validation of a short version of the Seattle angina questionnaire.

Authors:  Paul S Chan; Philip G Jones; Suzanne A Arnold; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-09-02

8.  Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.

Authors:  Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-07

9.  Effect of PCI on quality of life in patients with stable coronary disease.

Authors:  William S Weintraub; John A Spertus; Paul Kolm; David J Maron; Zefeng Zhang; Claudine Jurkovitz; Wei Zhang; Pamela M Hartigan; Cheryl Lewis; Emir Veledar; Jim Bowen; Sandra B Dunbar; Christi Deaton; Stanley Kaufman; Robert A O'Rourke; Ron Goeree; Paul G Barnett; Koon K Teo; William E Boden; G B J Mancini
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

10.  Rethinking composite end points in clinical trials: insights from patients and trialists.

Authors:  Joshua M Stolker; John A Spertus; David J Cohen; Philip G Jones; Kaushik K Jain; Emily Bamberger; Brady B Lonergan; Paul S Chan
Journal:  Circulation       Date:  2014-09-08       Impact factor: 29.690

View more
  3 in total

1.  All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study.

Authors:  Luca Degli Esposti; Valentina Perrone; Chiara Veronesi; Stefano Buda; Roberta Rossini
Journal:  Vasc Health Risk Manag       Date:  2018-11-20

2.  Translation and psychometric testing of the Farsi version of the Seattle angina questionnaire.

Authors:  Zahra Taheri-Kharameh; Majideh Heravi-Karimooi; Nahid Rejeh; Ebrahim Hajizadeh; Mojtaba Vaismoradi; Sherrill Snelgrove; Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2017-12-02       Impact factor: 3.186

3.  When a Short-Term Outlook Is the Best Long-Term Strategy: Time-Varying Risk of Readmission After Acute Myocardial Infarction.

Authors:  Andrew E Levy; Larry A Allen
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.